Tobacco use: A chronic illness?

Journal of Community Health

Volumn 35, Issue 5, 2010, Pages 549-553

  Hudson, Naomi L ^a   Mannino, David M ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular disease; Chronic disease; Diabetes; Hypertension; Mortality; Tobacco use

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; RISK FACTOR; SMOKING; UNITED STATES;

AGED; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; UNITED STATES;

EID: 78650204745     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-010-9241-x     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. (2004). Indicators for chronic disease surveillance. MMWR Recommendations and Reports, 53, 1-6.
2. Lee, C., & Kahende, J. (2007). Factors associated with successful smoking cessation in the United States, 2000. American Journal of Public Health, 97, 1503-1509.
3. American Heart Association. (2007). Cardiovascular disease statistics. American Heart Association. http://www.americanheart.org/presenter.jhtml? identifier=4478.
4. Fiore, M. C., Croyle, R. T., Curry, S. J., Cutler, C. M., Davis, R. M., Gordon, C., et al. (2004). Preventing 3 million premature deaths and helping 5 million smokers quit: A national action plan for tobacco cessation. American Journal of Public Health, 94, 205-210.
5. American Cancer Society. (2007). Prevention and early detection: Cigarette smoking. American Cancer Society. http://www.cancer.org/docroot/PED/ content/PED-10-2x-cigarette-smoking.asp.
6. Enright, P. L., Kronmal, R. A., Higgins, M. W., Schenker, M. B., & Haponik, E. F. (1994). Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular health study. Chest, 106, 827-834.
7. Gritz, E. R., Vidrine, D. J., & Fingeret, M. C. (2007). Smoking cessation a critical component of medical management in chronic disease populations. American Journal of Preventive Medicine, 33, S414-S422.
8. Li, R., Folsom, A., Sharrett, A. R., Couper, D., Bray, M., & Tyroler, H. A. (2001). Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: The atherosclerosis risk in communities (ARIC) study. Atherosclerosis, 154, 729-738.
9. Wattanakit, K., Folsom, A. R., Chambless, L. E., & Nieto, F. J. (2005). Risk factors for cardiovascular event recurrence in the atherosclerosis risk in communities (ARIC) study. American Heart Journal, 149, 606-612.
10. Kaur, J., Singh, P., & Sowers, J. R. (2002). Diabetes and cardiovascular disease. American Journal of Therapeutics, 9, 510-515.
11. Kuller, L. H., Velentgas, P., Barzilay, J., Beauchamp, N. J., O'Leary, D. H., & Savage, P. J. (2000). Diabetes mellitus: Subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 823-829.
12. Anthonisen, N. R. (2005). The effects of a smoking cessation intervention on 14.5-year mortality-response. Annals of Internal Medicine, 143, 615.
13. Schroeder, E. B., Welch, V. L., Evans, G. W., & Heiss, G. (2005). Impaired lung function and subclinical atherosclerosis. The ARIC study. Atherosclerosis, 180, 367-373.
14. Mannino, D. M., Doherty, D. E., & Buist, A. S. (2006). Global initiative on obstructive lung disease (GOLD) classification of lung disease and mortality: Findings from the atherosclerosis risk in communities (ARIC) study. Respiratory Medicine, 100, 115-122.
15. Atherosclerosis risk in communities study: Community surveillance and cohort morbidity/mortality follow-up manual 1 general description and study management version 5.0. (2006).
16. Atherosclerosis risk in communities study. University of North Carolina School of Public Health. (2008).
17. Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176, 532-555.
18. Rijken, M., van Kerkhof, M., Dekker, J., & Chellevis, F. G. (2005). Comorbidity of chronic diseases: Effects of disease pairs on physical and mental functioning. Quality of Life Research, 14, 45-55.
19. Li, R. L., Boerwinkle, E., Olshan, A. F., Chambless, L. E., Pankow, J. S., Tyroler, H. A., et al. (2000). Glutathione Stransferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis, 149, 451-462.
20. Khurana, S., Batra, V., Patkar, A. A., & Leone, F. T. (2003). Twenty-first century tobacco use: It is not just a risk factor anymore. Respiratory Medicine, 97, 295-301.
21. Olshan, A. F., Li, R., Pankow, J. S., Bray, M., Tyroler, H. A., Chambless, L. E., et al. (2003). Risk of atherosclerosis: Interaction of smoking and glutathione S-transferase genes. Epidemiology, 14, 321-327.